title: Prolonged allograft ischemic time is not associated with higher incidence of antibody-mediated rejection.
authors.forename: Arun K
authors.initials: AK
authors.lastname: Singhal
authors.forename: Stavros G
authors.initials: SG
authors.lastname: Drakos
authors.forename: Abdallah G
authors.initials: AG
authors.lastname: Kfoury
authors.forename: Benjamin D
authors.initials: BD
authors.lastname: Horne
authors.forename: Divya Ratan
authors.initials: DR
authors.lastname: Verma
authors.forename: Josef
authors.initials: J
authors.lastname: Stehlik
mesh_terms: D000328:Adult; D000906:Antibodies / Q000097:blood; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000379:methods*; D006801:Humans; D015994:Incidence; D015428:Myocardial Reperfusion Injury; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000906:Antibodies